Testa Center is an initiative between the Swedish government and Cytiva to secure the growth of the life science industry and its manufacturing capabilities. The main objective is to bridge the gap from discovery to industrialization.

This is achieved by our three pillars;

1) Acceleration of industrialization 2) Verification of innovations, and 3) Secure excellence.

The Testa Center offers businesses and academia worldwide a modern, pilot-scale testbed for projects and education in the production of biological products e.g. monoclonal antibodies, peptides, protein, vaccine, and viral vectors (non-GMP, up to Bio-safety level 2 and 500 liter).

In the flexible, open, non-GMP, production-like facility, and with the helping hands of the experienced Testa Center staff, project teams perform a wide variety of projects. E.g. scale-up of parts of a process for monoclonal antibodies, peptides, and proteins. Or a complete process scale-up, from frozen cell bank vial to purified protein.

The Testa Center has the expertise and the equipment to help your team scale up from lab bench-scale production to industrial-scale.

Testa Center is operated as a non-profit company and is fully owned by Cytiva.

The company name is Cytiva Testa Center AB. The brand name is Testa Center.